MAZE COMPASS
DEAD

Serial Number

90800797

Owner

Maze Therapeutics, Inc.

Attorney

Joyce Liou

Filing Date

Jun 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MAZE COMPASS Trademark

Serial Number: 90800797

MAZE COMPASS is a trademark filed by Maze Therapeutics, Inc. on June 29, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Maze Therapeutics, Inc. (4 trademarks)

171 Oyster Point Boulevard, Suite 300
San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

June 29, 2021

Registration Date

Not Registered

Published for Opposition

May 3, 2022

Goods & Services

Downloadable project management and planning software in the field of scientific, medical, and pharmaceutical research and development; Downloadable bioinformatics software for collecting, analyzing, and translating genetic data in the fields of scientific, medical, and pharmaceutical research and development; Downloadable software for collecting, analyzing and translating data and information in the field of pharmaceutical product testing; Downloadable computer software for the collection, analysis, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information in the fields of scientific, medical, and pharmaceutical research and development; Downloadable software for accessing an online database of disease and genetic information; Downloadable software for genetic mapping; Downloadable software for analyzing disease susceptibility, the timing of disease onset, and rate of disease progression; Downloadable software for analyzing disease vulnerabilities and generating therapeutic target recommendations in the nature of genes, proteins, and genetic mechanisms; Downloadable data analytics software for collecting, analyzing, and translating genetic data in the fields of scientific, medical, and pharmaceutical research and development; Downloadable software for identifying drug targets, optimizing and enhancing ability of compounds to drug the targets, and identifying patients who would best benefit from drug treatment

Providing online non-downloadable project management and planning software in the field of scientific, medical, and pharmaceutical research and development; Providing online non-downloadable bioinformatics software for collecting, analyzing, and translating genetic data in the fields of scientific, medical, and pharmaceutical research and development; Providing online non-downloadable software for collecting, analyzing, and translating data and information in the field of pharmaceutical product testing; Providing online non-downloadable computer software for the collection, analysis, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information in the fields of scientific, medical, and pharmaceutical research and development; Providing online non-downloadable software for accessing an online database of disease and genetic information; Providing online non-downloadable software for genetic mapping; Providing online non-downloadable software for analyzing disease susceptibility, the timing of disease onset, and rate of disease progression; Providing online non-downloadable software for analyzing disease vulnerabilities and generating therapeutic target recommendations in the nature of genes, proteins, and genetic mechanisms; Providing online non-downloadable data analytics software for collecting, analyzing, and translating genetic data in the fields of scientific, medical, and pharmaceutical research and development; Providing online non-downloadable software for identifying drug targets, optimizing and enhancing ability of compounds to drug the targets, and identifying patients who would best benefit from drug treatment; Electronic data storage in the field of scientific, medical, and pharmaceutical research and development; Software design and development services in the field of scientific, medical, and pharmaceutical research and development; Technical support services in the field of scientific, medical, and pharmaceutical research and development, namely, troubleshooting computer software problems, and services in the nature of customization, installation, updating, maintenance, and repair of computer software

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 4, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 4, 2025 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 20, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 20, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 20, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 20, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 20, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 23, 2024 EXRA
SOU EXTENSION 5 GRANTED
Dec 23, 2024 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 20, 2024 AITU
SOU EXTENSION 5 FILED
Nov 12, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jun 7, 2024 EX4G
SOU EXTENSION 4 FILED
Jun 7, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 7, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 23, 2023 EXRA
SOU EXTENSION 3 GRANTED
Dec 21, 2023 EX3G
SOU EXTENSION 3 FILED
Dec 21, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 21, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jun 22, 2023 EX2G
SOU EXTENSION 2 FILED
Jun 22, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 16, 2022 EXRA
SOU EXTENSION 1 GRANTED
Dec 14, 2022 EX1G
SOU EXTENSION 1 FILED
Dec 14, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 14, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 28, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 3, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 3, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 29, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 29, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 29, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 29, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 29, 2022 CNEA
ASSIGNED TO EXAMINER
Mar 21, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 10, 2021 NWOS
NEW APPLICATION ENTERED
Jul 2, 2021 NWAP